title: Comment on "treat-to-target in spondyloarthritis: implications for clinical trial designs".
authors.affiliation: Department of Rheumatology, University Teaching Hospital, CHRU de Besançon, Besançon, France, daniel.wendling@ufc-chu.univ-fcomte.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D025241:Spondylarthritis / Q000188:drug therapy*